Drug · DIN 02531577
BOTOX
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 20, 2023; first marketed June 20, 2023.
- Drug Identification Number (DIN)
- 02531577
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Schedule d; Prescription
- Dosage form
- Powder For Solution
- Route
- Intramuscular; Intradermal; Intradetrusorial
- Therapeutic class (ATC)
- Botulinum toxin M03AX01
- Class
- Human
- Record last updated
- May 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ONABOTULINUMTOXINA | 50 UNIT | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 3, 2022: NOC 29123Supplement to a New Drug Submission (SNDS) · Labelling updates
Other DINs named BOTOX
- DIN 01981501 · Marketed
- DIN 02531585 · Marketed